AA
RVMD icon

ALPS Advisors’s Revolution Medicines RVMD Stock Holding History

ALPS Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$413K Buy
+2,204
New +$322K ﹤0.01% 1039
2024
Q2 		– Sell
-116,156
Closed -$3.74M – 994
2024
Q1 		$3.74M Buy
116,156
+4,952
+4% +$147K 0.03% 268
2023
Q4 		$3.19M Buy
+111,204
New +$2.67M 0.03% 277

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

ALPS Advisors's RVMD Position: Q2 2026 in Review

ALPS Advisors opened a new position in Revolution Medicines (RVMD) in Q2 2026: 2,204 shares worth $413K. The stake represents ﹤0.01% of the portfolio and ranks #1039 among its holdings. This is a return to the name: ALPS Advisors previously reported a position in RVMD as recently as Q1 2024.

ALPS Advisors first reported a position in RVMD in Q4 2023 and has held it in 3 quarters since. The position peaked at $3.74M in Q1 2024. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • ALPS Advisors held 2,204 shares of Revolution Medicines worth $413K as of Q2 2026.
  • Revolution Medicines was a new ALPS Advisors position in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #1039 holding.
  • ALPS Advisors first reported a position in Revolution Medicines in Q4 2023 and has held it in 3 quarters since.
  • ALPS Advisors's Revolution Medicines position peaked at $3.74M in Q1 2024.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.